Gedea Biotech
PrivateLast Round
Grant
Feb 29, 2024
Total Funding Raised
$5.03M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gedea Biotech is a biotechnology company that develops pHyph, an antibiotic-free treatment for vaginal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gedea Biotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Gedea Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 29, 2024 | ||||
| VC Round | Nov 15, 2023 | ||||
| VC Round | May 24, 2023 | ||||
| Grant | Apr 4, 2023 | ||||
| VC Round | Oct 28, 2021 | ||||
Grant | Dec 11, 2019 |
Key People
Founding team and executive leadership
Gedea Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Almi Invest AB | Seed |
| Vinnova | Grant |
| Porte-Monnaie Venture | Seed |
| Swelife | Grant |
| LU Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 182% MoM, reaching 1.3K.
- Jan 27, 2026
Julie Waras Brogren appointed as new CEO.
Gedea Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gedea Biotech's valuation, stock price, and market status.